# FDA recall D-0866-2026

> **VITRUVIAS THERAPEUTICS INC** · Class I · drug recall initiated 2026-08-21.

## Product

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

## Reason for recall

Superpotent Drug

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0866-2026
- **Recalling firm:** VITRUVIAS THERAPEUTICS INC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-08-21
- **Report date:** 2026-09-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Auburn, AL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0866-2026

## Citation

> MORVS. FDA recall D-0866-2026. Retrieved 2026-10-22 from https://api.morvs.ai/recall/D-0866-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*